ZH

ATIF Holdings Limited Announces Results of 2022 Annual General Meeting

Retrieved on: 
Thursday, July 28, 2022
CA, Golden Bauhinia Awards, IPO, Industry, U.S. Securities and Exchange Commission, Forward-looking statement, Compliance, Annual general meeting, Collection, Private Securities Litigation Reform Act, Income, Board, Annual, News, ZH, Special-purpose acquisition company, Policy, Company, Board of directors, Blockchain, Security (finance), Nasdaq, Annual report, Form 20-F, LLC, Growth, NFT, Public expenditure, ATIF, Holding company

IRVINE, Calif., July 28, 2022 /PRNewswire/ -- ATIF Holdings Limited (Nasdaq: ATIF) (the "Company," "ATIF" or "We"), a holding company providing business and financial consulting services in Asia and North America, today announced the results of its 2022 Annual General Meeting, which was held on July 25, 2022 in Lake Forest, CA.

Key Points: 
  • IRVINE, Calif., July 28, 2022 /PRNewswire/ -- ATIF Holdings Limited (Nasdaq: ATIF) (the "Company," "ATIF" or "We"), a holding company providing business and financial consulting services in Asia and North America, today announced the results of its 2022 Annual General Meeting, which was held on July 25, 2022 in Lake Forest, CA.
  • At the Annual General Meeting, the Company's shareholders:
    (1) elected Messrs. Jun Liu, Kwong Sang Liu and Yongyuan Chen and Mses.
  • ATIF Holdings Limited ("ATIF") is a holding group with business consulting, asset management, and investment businesses, with offices in Los Angeles, California, Hong Kong, and Shenzhen, China.
  • ATIF has advised several enterprises in China in their plans to become publicly listed in the United States.

Levada – our new ski racing suit

Retrieved on: 
Tuesday, July 5, 2022
Athlete, CEO, JED, World cup, Levada, Ken Read, World, Partnership, Sport, Descente, Sports equipment, Entertainment, ZH

The secret has been revealed the design of the new Descente alpine ski racing suit for Swiss-Ski athletes is no longer under wraps.

Key Points: 
  • The secret has been revealed the design of the new Descente alpine ski racing suit for Swiss-Ski athletes is no longer under wraps.
  • Following its 51 World Cup podium places and nine Olympic medals last winter, the Swiss alpine team is set to enter the upcoming competition season with new colors and a new racing suit called Levada.
  • The racing suit is a key element for athletes on the road to success and every detail counts.
  • Its a motto and a name that should also give Swiss-Ski athletes an additional motivational boost when they put on their racing suit.

Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List

Retrieved on: 
Wednesday, April 13, 2022
Venus, ZH, Forbes China Celebrity 100, Health, Hong Kong Exchanges and Clearing, Duane, CanSino Biologics, Poverty, Taipei Exchange, NASDAQ, Social responsibility, VC, Partner, Science, San Francisco Bay Area, AUM, Gan, Midas List, CNY, ESG, Gold, Artificial intelligence, PharmAccess Foundation, Efficiency, Shenzhen Stock Exchange, LP record, Technology, Environment, Ecosystem, Female, AI, NYSE, Semiconductor, Xiaomi, TMT, Blockchain, Software as a service, Forbes, Shanghai Stock Exchange, Food delivery, Healthcare, Pharmaceutical industry, Renewable energy, Bank, UBtech Robotics, Unisound, Midas, Qiming Venture Partners

SHANGHAI, April 12, 2022 /PRNewswire/ Forbes released the 2022 Midas List on April 12, a ranking of the world's top 100 venture capitalists.

Key Points: 
  • SHANGHAI, April 12, 2022 /PRNewswire/ Forbes released the 2022 Midas List on April 12, a ranking of the world's top 100 venture capitalists.
  • Nisa Leung, Managing Partner of Qiming Venture Partners, and Duane Kuang, Founding Managing Partner of Qiming Venture Partners, ranked on the list.
  • Nisa has been on the list for four consecutive years, ranking No.61 and up 12 places from last year.
  • Duane has been named on the Midas list for the third time, ranking No.74 this year.

Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market

Retrieved on: 
Wednesday, March 30, 2022
Venus, Qiming Venture Partners, CanSino Biologics, Biotechnology, USD, Respiration, NASDAQ, Shanghai Stock Exchange STAR Market, SESH, Shanghai Stock Exchange, Diagnosis, National Medical Products Administration, CDC, Shenzhen Stock Exchange, Growth, NYSE, Star Market, ZH, Centers for Disease Control and Prevention, Digestion, Hepatitis, Hospital, Hong Kong Exchanges and Clearing, Science, CNY, RNA, NMPA, UBtech Robotics, RMB, SAT, Center, Technology, AUM, Gan, Time, COVID-19, TMT, San Francisco Bay Area, Partner, Solution, HBV, IPO, Blood, Frost & Sullivan, Food, Taipei Exchange, Reproduction, Fine chemical, Security (finance), Vaccine, Rendu

SHANGHAI, March 29, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company Rendu Biotechnology (SESH: 688193), a leader in RNA molecular diagnostics in China, today listed on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange.

Key Points: 
  • SHANGHAI, March 29, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company Rendu Biotechnology (SESH: 688193), a leader in RNA molecular diagnostics in China, today listed on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange.
  • Qiming Venture Partners is the earliest investor in Rendu Biotechnology and led the company's Series A financing round in 2013.
  • The successful listing of Rendu also marks the third IPO in Qiming's portfolio in 2022.
  • In addition, Rendu Biotechnology launched AutoSAT, the first fully automatic, high-throughput, and full-process integrated platform for nucleic acid detection in China's molecular diagnostic space.

Qiming Venture Partners Welcomes David Chu as IR Partner

Retrieved on: 
Wednesday, March 2, 2022
Venus, Partners Group, Shenzhen Stock Exchange, Qiming Venture Partners, AUM, Taipei Exchange, USD, Partner, Hong Kong Exchanges and Clearing, NYSE, TMT, CanSino Biologics, NASDAQ, UBtech Robotics, Gan, History, Technology, San Francisco Bay Area, Partnership, Publication, Shanghai Stock Exchange, ZH, Pharmaceutical industry, Private investigator, Bank

SHANGHAI, March 1, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce that David Chu has joined the firm as a Partner, focusing on fundraising and investor relations for Qiming's USD funds.

Key Points: 
  • SHANGHAI, March 1, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce that David Chu has joined the firm as a Partner, focusing on fundraising and investor relations for Qiming's USD funds.
  • He has over 20 years of experience in the venture capital ecosystem as a limited partner, financial advisor to entrepreneurs, and venture capitalist.
  • David Chu said, "I am excited to be joining Qiming, a firm I have admired for its exceptional investment track record and outstanding reputation amongst entrepreneurs and limited partners.
  • Grace Lee, Partner & Group COO, said, "David has brought with him more than a decade of limited partner and venture capital experience.

Qiming Venture Partners Announces Annual Promotions

Retrieved on: 
Friday, January 7, 2022
Venus, Hong Kong Exchanges and Clearing, UBtech Robotics, Internet, Shenzhen Stock Exchange, Patient, NYSE, TMT, CanSino Biologics, Taipei Exchange, Gan, Qiming Venture Partners, NASDAQ, Shanghai Stock Exchange, ZH, AUM, San Francisco Bay Area, Generation Z, Technology, Security (finance), Partner

SHANGHAI, Jan. 7, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce the promotions of Bonnie Wang and Dr. Kan Chen to Partner, and Xiaofei Zhou to Vice President.

Key Points: 
  • SHANGHAI, Jan. 7, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce the promotions of Bonnie Wang and Dr. Kan Chen to Partner, and Xiaofei Zhou to Vice President.
  • Dr. Kan Chen joined Qiming Venture Partners in 2016, where he was involved with several industry-leading companies in the innovative drug sector.
  • Qiming Venture Partners congratulates the eleven team members on their promotions and accomplishments.
  • Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.

Shiyu Wang Rejoins Qiming Venture Partners as Partner, Co-Leads TMT Team

Retrieved on: 
Tuesday, January 4, 2022
Venus, Growth, Partner, Culture, Taipei Exchange, Social, Hong Kong Exchanges and Clearing, TMT, UBtech Robotics, Qiming Venture Partners, CanSino Biologics, NASDAQ, Partnership, LP, San Francisco Bay Area, Gan, NYSE, Publication, Shenzhen Stock Exchange, ZH, AUM, Shanghai Stock Exchange, History, Time, Internet, Financial services

SHANGHAI, Jan. 3, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce that Shiyu Wang has rejoined the firm as a Partner.

Key Points: 
  • SHANGHAI, Jan. 3, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce that Shiyu Wang has rejoined the firm as a Partner.
  • Shiyu Wang has many years of investment experience in the internet and consumer industries, having previously worked at Qiming Venture Partners from 2012 to 2016.
  • From start-up to rapid growth, Qiming Venture Partners, as a venture capital firm in China, has gone through 15 years of history.
  • Qiming Venture Partners has also been ranked as a leading fund in China's venture capital industry by numerous agencies and publications.

EQS-News: MySports supports the Sunrise UPC growth strategy

Retrieved on: 
Friday, September 3, 2021
Football League First Division, Instagram, Athlete, Twitter, National, ZH, National League, Heart, News, Hoodie, Partnership, Sport, Erlenbach, YouTube, Emotion, Sky, Facebook, UPC, Sunrise, Lady Blue (TV series), Social media, Swiss League, Program, FC Basel, Hockey, Telecommunication, CEO, Personality, Sale, Sunrise Communications AG, Television, Entertainment

Thanks to the combined expertise in telecommunications and TV at Sunrise UPC, fans and viewers will benefit even more in the future.

Key Points: 
  • Thanks to the combined expertise in telecommunications and TV at Sunrise UPC, fans and viewers will benefit even more in the future.
  • Homemade documentaries, eNational League events, the PUCK OFF podcast and MySports' engagement on social media will be expanded further.
  • Sunrise UPC aims to redefine how MySports viewers enjoy sports, leveraging possibilities in telecommunications over the next five years.
  • Sunrise UPC is just a slapshot away from the start of the season and guarantees great excitement - far beyond the hockey arena.